CN1141126C - Chinese medicine composition for treating cancer - Google Patents
Chinese medicine composition for treating cancer Download PDFInfo
- Publication number
- CN1141126C CN1141126C CNB011182229A CN01118222A CN1141126C CN 1141126 C CN1141126 C CN 1141126C CN B011182229 A CNB011182229 A CN B011182229A CN 01118222 A CN01118222 A CN 01118222A CN 1141126 C CN1141126 C CN 1141126C
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- herba
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a Chinese medicinal herb composition for treating cancer. The present invention is prepared from cornu rhinoceri, cow bezoar, edible tulip, radix isatidis, mongolian dandelion herb, hedyotic diffusa, black nightshade herb, weeping forsythiae capsule, squama manis, musk, bistortae, Sichuan fritillaria, red peony root, gleditsia thorn, common selfheal fruit-spike, kelp, eastern bracken fern rhizome, american ginseng, angelica, Radix Rehmanniae Preparata, radix paeoniae alba, red sage root, rhubarb, virgate wormwood herb, muskroot-like semiaquilegia root, rhizoma and common dysosmatis rhizome and root. If the present invention is used for patients with hydrops, stir-baked euphorbia pekinensis with vinegar and stir-fried cantharis with rice are used, otherwise the two medicines are not used.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of cancer, have heat-clearing and toxic substances removing, joint, repercussive softening the hard mass, an inrigorating qi and promoting blood circulation effect treating stranguria, the granulation promoting of getting rid of evils that nourishes blood, subsides a swelling of loosing of reducing phlegm.
Background technology
Cancer is the fiendish killer of current harm humans health.Human body is many to cause disorder of QI and blood owing to be subjected to the influence of various inside and outside boundaries factor, and the expectorant stasis of blood is handed over resistance, and pyretic toxicity condenses, and causes coagulation of QI-blood, and phlegm and blood stasis is not changed the formation cancer.The traditional Chinese medical science is taked heat-clearing and toxic substances removing, the pain relieving of reducing phlegm, inrigorating qi and promoting blood circulation are nourished blood, the repercussive softening the hard mass looses joint, strengthening vital QI to eliminate pathogenic factors and control it.
Summary of the invention
The application's purpose just provides a kind of Chinese medicine composition for the treatment of cancer.The applicant is on the basis of clinical research in 40 years, principle according to traditional Chinese medical science strengthening vital QI to eliminate pathogenic factors, form this compositions, it can strengthen human immune system's function, suppresses growth of cancers, and detumescence is loose and saved toxin expelling, the removing the necrotic tissue and promoting granulation pain relieving, improve patient's life quality, prolong life, can be used in the various cancers of treatment.
The common weight ratio of the application's Chinese medicine composition raw material is (1) Cornu rhinocerotis 2, Calculus Bovis 0.4, Moschus 0.2, Radix Panacis Quinquefolii 4-5, reaches (2) Pseudobulbus cremastrae seu pleiones 3-6, Radix Isatidis 5-10, Herba Taraxaci 5-10, Herba Hedyotidis Diffusae 10-15, Herba Solani Nigri 10-15, Fructus Forsythiae 5-10, Squama Manis 3-6, Rhizoma Paridis 3-15, Bulbus Fritillariae Cirrhosae 3-10, Radix Paeoniae Rubra 5-10, day fourth 2-5, Spica Prunellae 3-10, Thallus Laminariae (Thallus Eckloniae) 5-15, Rhizoma pteridii latiusculi 5-15, Radix Angelicae Sinensis 5-15, Radix Rehmanniae Preparata 5-15, Radix Paeoniae Alba 5-15, Radix Salviae Miltiorrhizae 5-15, Radix Et Rhizoma Rhei 2-15, Herba Artemisiae Scopariae 5-15, Radix Semiaquilegiae 5-10, Rhizoma Smilacis Glabrae 5-10, Radix et Rhizoma Dysosmatis 3-10.In clinical use, can suitably adjust the wherein consumption of each component according to the concrete state of an illness.The preferred weight proportion of the raw material of this compositions is (1) Cornu rhinocerotis 2, Calculus Bovis 0.4, Moschus 0.2, Radix Panacis Quinquefolii 4, reaches (2) Pseudobulbus cremastrae seu pleiones 3, Radix Isatidis 4, Herba Taraxaci 4, Herba Hedyotidis Diffusae 5, Herba Solani Nigri 6, Fructus Forsythiae 3, Squama Manis 3, Rhizoma Paridis 4, Bulbus Fritillariae Cirrhosae 3, Radix Paeoniae Rubra 4, day fourth 2, Spica Prunellae 3, Thallus Laminariae (Thallus Eckloniae) 4, Rhizoma pteridii latiusculi 4, Radix Angelicae Sinensis 5, Radix Rehmanniae Preparata 4, the Radix Paeoniae Alba 4, Radix Salviae Miltiorrhizae 4, Radix Et Rhizoma Rhei 2, Herba Artemisiae Scopariae 4, Radix Semiaquilegiae 4, Rhizoma Smilacis Glabrae 3, Radix et Rhizoma Dysosmatis 4.
The Fang Xiewei of this compositions:
1. heat-clearing and toxic substances removing, eliminating stagnation person is a monarch drug
Cornu rhinocerotis, Calculus Bovis, Pseudobulbus cremastrae seu pleiones, Radix Isatidis, Herba Taraxaci, Herba Hedyotidis Diffusae, Herba Solani Nigri, Fructus Forsythiae, Radix et Rhizoma Dysosmatis
2. resolving phlegm and dissipating blood stasis softening the hard mass person is a ministerial drug
Moschus, Squama Manis, Radix Paeoniae Rubra, Bulbus Fritillariae Cirrhosae, day fourth, Rhizoma Paridis, Spica Prunellae, Rhizoma pteridii latiusculi, Thallus Laminariae (Thallus Eckloniae)
Inrigorating qi and promoting blood circulation, nourish blood, pain relieving person is for adjuvant drug
Radix Panacis Quinquefolii, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, the Radix Paeoniae Alba, Radix Salviae Miltiorrhizae
4. the treating stranguria person that subsides a swelling is a messenger drug
Radix Et Rhizoma Rhei, Herba Artemisiae Scopariae, Radix Semiaquilegiae, Rhizoma Smilacis Glabrae
The preparation method of the application's Chinese medicine composition is as follows
(1) group raw material Cornu rhinocerotis, Calculus Bovis, Moschus, Radix Panacis Quinquefolii are pulverized; (2) group raw material Pseudobulbus cremastrae seu pleiones, Radix Isatidis, Herba Taraxaci, Herba Hedyotidis Diffusae, Herba Solani Nigri, Fructus Forsythiae, Squama Manis, Rhizoma Paridis, Bulbus Fritillariae Cirrhosae, Radix Paeoniae Rubra, day fourth, Spica Prunellae, Thallus Laminariae (Thallus Eckloniae), Rhizoma pteridii latiusculi, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, the Radix Paeoniae Alba, Radix Salviae Miltiorrhizae, Radix Et Rhizoma Rhei, Herba Artemisiae Scopariae, Radix Semiaquilegiae, Rhizoma Smilacis Glabrae, Radix et Rhizoma Dysosmatis are fried in shallow oil into decoction with conventional method, behind the concentrate drying, mix with (1) group raw material, make tablet, powder, electuary or capsule, or after raw material mixes, add processed with honey and become pill with (1) group.
Used Cornu rhinocerotis can replace with Cornu Bubali 10-15 weight portion in the compositions.Preferable amount be 15 weight portions and as (2) group raw material.
If any hydrops, make capsule with stir-baked RADIX KNOXIAE with vinegar 2g and rice stir-baked MYLABRIS with rice 0.05g, be used, but do not have hydrops, the blood stasis person is forbidden this capsule.
Another instructions of taking of the application's Chinese medicine composition is: (1) group raw material pulverizing is made powder, (2) group raw material is made decoction, obey powder morning, obey decoction noon, obey the capsule that the Radix Euphorbiae Pekinensis and Mylabris are made evening.
Apply affected part with Cipangopaludina chinensis cream, ten thousand clever cream, Myogenic powder in addition, reach the acupuncture affected part, can strengthen the curative effect of the application's medicine.
The thing that life expectorant such as fasting sea raw meat, Radix Raphani, cattle, sheep, goose, chicken, Hepar Sus domestica, lean meat are lit a fire during the treatment.
The specific embodiment
Embodiment: get raw material by following weight; (1) Cornu rhinocerotis 2g; Calculus Bovis 0.4g; Moschus 0.2g; Radix Panacis Quinquefolii 4g; powder is made in pulverizing; (2) Pseudobulbus cremastrae seu pleiones 3-6g; Radix Isatidis 5-10g; Herba Taraxaci 5-10g; Herba Hedyotidis Diffusae 10-15g; Herba Solani Nigri 10-15g; Fructus Forsythiae 5-10g; Squama Manis 3-6g; Rhizoma Paridis 3-15; Bulbus Fritillariae Cirrhosae 3-10g; Radix Paeoniae Rubra 5-10g; it fourth 2-5g; Spica Prunellae 3-10g; Thallus Laminariae (Thallus Eckloniae) 5-15g; Rhizoma pteridii latiusculi 5-15g; Radix Angelicae Sinensis 5-15g; Radix Rehmanniae Preparata 5-15g; Radix Paeoniae Alba 5-15g; Radix Salviae Miltiorrhizae 5-15g; Radix Et Rhizoma Rhei 2-15g; Herba Artemisiae Scopariae 5-15g; Radix Semiaquilegiae 5-10g; Rhizoma Smilacis Glabrae 5-10g; Radix et Rhizoma Dysosmatis 3-10g; fry in shallow oil into decoction, (3) make capsule with stir-baked RADIX KNOXIAE with vinegar 2g and rice stir-baked MYLABRIS with rice 0.05g.
More than be dose for each person every day, obey powder morning, obey decoction noon, obey capsule evening.
Clinical application effect
The application's medicine can effectively be eliminated clinical symptoms through clinical use for many years, and curative effect is reliable, and late result is good, and relapse rate is low.Except that anemia of pregnant woman Ying Shen uses, have no side effect.Below be that clinical observation is summed up:
One. this medicine of physical data is made use for many years by oneself, and the patient of treatment is from twenties to seven teen age.All turn out to be cancer through clinical means such as CT examination, section, chemical examinations.Now collect 100 routine gastric cancer, esophageal carcinoma case is added up, the outpatient is the object of observation to grow up.
Two. Therapeutic Method is taken the pill of the application's pharmaceutical composition, divides every day by the dosage of embodiment and takes for 3 times, and each month is a course of treatment, generally takes medicine 2-6 month.
Three. efficacy assessment standard adopts self treatment front and back symptom contrast, presses the objective efficacy assessment standard evaluation of cancer therapy drug clinical research guideline solid tumor observing effect,
The positive sign of clinical cure symptom and inspection disappears, and recovers certain work capacity.
The produce effects symptom disappears substantially, and focus is dwindled, and every index of physical examination takes a turn for the better.
Effectively symptom makes moderate progress, and focus is basicly stable.
Through observing, the back most patients symptom of taking medicine obviously alleviates or disappears, and appetite increases, and life quality is improved, and part patient observes the tumor body and dwindles, and obvious effective rate 15% by statistics, and effective percentage 46%, total effective rate are 61%.
Other cancers of this Drug therapy are also received effect preferably.
Model case
1, Wang Linnan, 71 years old, old Red Army man.There was 1.7 * 1.2 centimetres lump on the bladder right side, was diagnosed as bladder cancer through CT examination in 1986, and is invalid through a plurality of hospitalizes.In October, 1986, I treated.Through looking into: the thin yellowish complexion of body, pale, yellow fur is thick, and the deep pulse number is favourable, xerostomia, stool is normal, and it is blood red urinate, inferior surplus urinating 10 every day.The excision of this person's earlier year, hands is touched the affected part hypodynia, and the little redness of affected part has 1 of lump.After 30 days, urine is normal, can leave the bed at my institute's medication treatment, obey 150 days again after, freedom of action, lump disappears, and gets well.Nineteen ninety-five pays a return visit, and the patient is normal.
Claims (10)
1, a kind of Chinese medicine composition for the treatment of cancer is characterized in that it is made by following two groups of materials of weight proportions: (1) Cornu rhinocerotis 2, Calculus Bovis 0.4, Moschus 0.2, Radix Panacis Quinquefolii 4-5; Reach (2) Pseudobulbus cremastrae seu pleiones 3-6, Radix Isatidis 5-10, Herba Taraxaci 5-10, Herba Hedyotidis Diffusae 10-15, Herba Solani Nigri 10-15, Fructus Forsythiae 5-10, Squama Manis 3-6, Rhizoma Paridis 3-15, Bulbus Fritillariae Cirrhosae 3-10, Radix Paeoniae Rubra 5-10, day fourth 2-5, Spica Prunellae 3-10, Thallus Laminariae (Thallus Eckloniae) 5-15, Rhizoma pteridii latiusculi 5-15, Radix Angelicae Sinensis 5-15, Radix Rehmanniae Preparata 5-15, Radix Paeoniae Alba 5-15, Radix Salviae Miltiorrhizae 5-15, Radix Et Rhizoma Rhei 2-15, Herba Artemisiae Scopariae 5-15, Radix Semiaquilegiae 5-10, Rhizoma Smilacis Glabrae 5-10, Radix et Rhizoma Dysosmatis 3-10.
2, a kind of Chinese medicine composition for the treatment of cancer is characterized in that it is made by following two groups of materials of weight proportions: (1) Cornu rhinocerotis 2, Calculus Bovis 0.4, Moschus 0.2, Radix Panacis Quinquefolii 4; Reach (2) Pseudobulbus cremastrae seu pleiones 3, Radix Isatidis 4, Herba Taraxaci 4, Herba Hedyotidis Diffusae 5, Herba Solani Nigri 6, Fructus Forsythiae 3, Squama Manis 3, Rhizoma Paridis 4, Bulbus Fritillariae Cirrhosae 3, Radix Paeoniae Rubra 4, day fourth 2, Spica Prunellae 3, Thallus Laminariae (Thallus Eckloniae) 4, Rhizoma pteridii latiusculi 4, Radix Angelicae Sinensis 5, Radix Rehmanniae Preparata 4, the Radix Paeoniae Alba 4, Radix Salviae Miltiorrhizae 4, Radix Et Rhizoma Rhei 2, Herba Artemisiae Scopariae 4, Radix Semiaquilegiae 4, Rhizoma Smilacis Glabrae 3, Radix et Rhizoma Dysosmatis 4.
3, a kind of Chinese medicine composition for the treatment of cancer is characterized in that it is made by following two groups of materials of weight proportions: (1) Calculus Bovis 0.4, Moschus 0.2, Radix Panacis Quinquefolii 4-5; Reach (2) Cornu Bubali 10-15, Pseudobulbus cremastrae seu pleiones 3-6, Radix Isatidis 5-10, Herba Taraxaci 5-10, Herba Hedyotidis Diffusae 10-15, Herba Solani Nigri 10-15, Fructus Forsythiae 5-10, Squama Manis 3-6, Rhizoma Paridis 3-15, Bulbus Fritillariae Cirrhosae 3-10, Radix Paeoniae Rubra 5-10, day fourth 2-5, Spica Prunellae 3-10, Thallus Laminariae (Thallus Eckloniae) 5-15, Rhizoma pteridii latiusculi 5-15, Radix Angelicae Sinensis 5-15, Radix Rehmanniae Preparata 5-15, Radix Paeoniae Alba 5-15, Radix Salviae Miltiorrhizae 5-15, Radix Et Rhizoma Rhei 2-15, Herba Artemisiae Scopariae 5-15, Radix Semiaquilegiae 5-10, Rhizoma Smilacis Glabrae 5-10, Radix et Rhizoma Dysosmatis 3-10.
4, a kind of Chinese medicine composition for the treatment of cancer is characterized in that it is made by following two groups of materials of weight proportions: (1) Calculus Bovis 0.4, Moschus 0.2, Radix Panacis Quinquefolii 4; Reach (2) Cornu Bubali 15, Pseudobulbus cremastrae seu pleiones 3, Radix Isatidis 4, Herba Taraxaci 4, Herba Hedyotidis Diffusae 5, Herba Solani Nigri 6, Fructus Forsythiae 3, Squama Manis 3, Rhizoma Paridis 4, Bulbus Fritillariae Cirrhosae 3, Radix Paeoniae Rubra 4, day fourth 2, Spica Prunellae 3, Thallus Laminariae (Thallus Eckloniae) 4, Rhizoma pteridii latiusculi 4, Radix Angelicae Sinensis 5, Radix Rehmanniae Preparata 4, the Radix Paeoniae Alba 4, Radix Salviae Miltiorrhizae 4, Radix Et Rhizoma Rhei 2, Herba Artemisiae Scopariae 4, Radix Semiaquilegiae 4, Rhizoma Smilacis Glabrae 3, Radix et Rhizoma Dysosmatis 4.
5, preparation is characterized in that (1) group raw material pulverizing according to the method for the described Chinese medicine composition of arbitrary claim in the claim 1,2,3 or 4; (2) group raw material is fried in shallow oil into decoction with conventional method, behind the concentrate drying, mixes, make tablet, powder, electuary or capsule, or, add processed with honey and become pill with after (1) organizes raw material and mix with (1) group raw material.
6, a kind of Chinese medicine composition for the treatment of cancer is characterized in that it is to make capsule by stir-baked RADIX KNOXIAE with vinegar 2-3 weight portion and rice stir-baked MYLABRIS with rice 0.05-0.06 weight portion.
7, a kind of Chinese medicine composition for the treatment of cancer is characterized in that it is by following materials of weight proportions: the powder that Cornu rhinocerotis 2, Calculus Bovis 0.4, Moschus 0.2, Radix Panacis Quinquefolii 4-5 make.
8, a kind of Chinese medicine composition for the treatment of cancer is characterized in that it is by following materials of weight proportions: the decoction that Pseudobulbus cremastrae seu pleiones 3-6, Radix Isatidis 5-10, Herba Taraxaci 5-10, Herba Hedyotidis Diffusae 10-15, Herba Solani Nigri 10-15, Fructus Forsythiae 5-10, Squama Manis 3-6, Rhizoma Paridis 3-15, Bulbus Fritillariae Cirrhosae 3-10, Radix Paeoniae Rubra 5-10, day fourth 2-5, Spica Prunellae 3-10, Thallus Laminariae (Thallus Eckloniae) 5-15, Rhizoma pteridii latiusculi 5-15, Radix Angelicae Sinensis 5-15, Radix Rehmanniae Preparata 5-15, Radix Paeoniae Alba 5-15, Radix Salviae Miltiorrhizae 5-15, Radix Et Rhizoma Rhei 2-15, Herba Artemisiae Scopariae 5-15, Radix Semiaquilegiae 5-10, Rhizoma Smilacis Glabrae 5-10, Radix et Rhizoma Dysosmatis 3-10 make.
9, a kind of Chinese medicine composition for the treatment of cancer is characterized in that it is by following materials of weight proportions: the powder that Calculus Bovis 0.4, Moschus 0.2, Radix Panacis Quinquefolii 4-5 make.
10, a kind of Chinese medicine composition for the treatment of cancer is characterized in that it is by following materials of weight proportions: the decoction that Cornu Bubali 10-15, Pseudobulbus cremastrae seu pleiones 3-6, Radix Isatidis 5-10, Herba Taraxaci 5-10, Herba Hedyotidis Diffusae 10-15, Herba Solani Nigri 10-15, Fructus Forsythiae 5-10, Squama Manis 3-6, Rhizoma Paridis 3-15, Bulbus Fritillariae Cirrhosae 3-10, Radix Paeoniae Rubra 5-10, day fourth 2-5, Spica Prunellae 3-10, Thallus Laminariae (Thallus Eckloniae) 5-15, Rhizoma pteridii latiusculi 5-15, Radix Angelicae Sinensis 5-15, Radix Rehmanniae Preparata 5-15, Radix Paeoniae Alba 5-15, Radix Salviae Miltiorrhizae 5-15, Radix Et Rhizoma Rhei 2-15, Herba Artemisiae Scopariae 5-15, Radix Semiaquilegiae 5-10, Rhizoma Smilacis Glabrae 5-10, Radix et Rhizoma Dysosmatis 3-10 make.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011182229A CN1141126C (en) | 2001-05-23 | 2001-05-23 | Chinese medicine composition for treating cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011182229A CN1141126C (en) | 2001-05-23 | 2001-05-23 | Chinese medicine composition for treating cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1386524A CN1386524A (en) | 2002-12-25 |
| CN1141126C true CN1141126C (en) | 2004-03-10 |
Family
ID=4663044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB011182229A Expired - Fee Related CN1141126C (en) | 2001-05-23 | 2001-05-23 | Chinese medicine composition for treating cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1141126C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100400088C (en) * | 2004-05-28 | 2008-07-09 | 张海峰 | Anticanser medicine |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101007056B (en) * | 2006-01-24 | 2012-02-29 | 江苏康缘药业股份有限公司 | An antitumor medicinal composition and its preparation method |
| CN102397476B (en) * | 2011-11-30 | 2013-04-03 | 牛德兴 | Chinese medicinal pigmentum for treating acute herpes zoster |
-
2001
- 2001-05-23 CN CNB011182229A patent/CN1141126C/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100400088C (en) * | 2004-05-28 | 2008-07-09 | 张海峰 | Anticanser medicine |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1386524A (en) | 2002-12-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100563690C (en) | A kind of medicine for the treatment of rheumatism, rheumatoid, puerperal exposure to wind, hyperosteogeny and disease of proplapse of lumbar intervertebral disc | |
| CN103893727B (en) | A kind of relieving pain and activating blood circulation relaxing muscles and tendons plaster and preparation method thereof | |
| CN101049368A (en) | Oral and external remedy for curing psoriasis | |
| CN1329045C (en) | Chinese medicine for treating cancer | |
| CN101675948A (en) | Traditional Chinese medicine composition for treating apoplexy | |
| CN101181568B (en) | Traditional chinese medicine preparation for curing osteoproliferation as well as arthrosis ache | |
| CN1305515C (en) | Chinese medicine powder and decoction composition for treating cancers | |
| CN102114230A (en) | Medicament for treating psoriasis | |
| CN1141126C (en) | Chinese medicine composition for treating cancer | |
| CN103599455B (en) | Traditional Chinese medicine capsule for removing freckle | |
| CN101856455B (en) | Chinese medicament for treating psoriasis vulgaris | |
| CN104324350A (en) | Traditional Chinese medicine composition for chronic colitis and preparation method of traditional Chinese medicine composition | |
| CN102228576B (en) | Chinese patent medicine for treating discoid lupus erythematosus | |
| CN100427132C (en) | Traditional Chinese medicine for treating rheumatism and its preparing process | |
| CN105106786B (en) | The external medicine composition and its preparation and preparation method of a kind of Tongluo Shujin | |
| CN1314409C (en) | Medicine for inhibiting and eliminating cancer | |
| CN102018765A (en) | Traditional Chinese medicine for treating diabetic acromelic gangrene | |
| CN100411670C (en) | Medicine for treating tumor in upper digestive tract and its preparing method | |
| CN105168774A (en) | Traditional Chinese medicine preparation for treating scapulohumeral periarthritis and preparation method thereof | |
| CN105381177A (en) | External use traditional Chinese medicine for treating sweet stains | |
| CN104491683A (en) | Traditional Chinese medicine composition for treating verruca plana and preparation method of traditional Chinese medicine composition | |
| CN104524204A (en) | Traditional Chinese medicine preparation for treating wounds and malignant sores and preparation method of traditional Chinese medicine preparation | |
| CN103566224A (en) | Traditional Chinese medicine composition for treating numbness of limbs | |
| CN104721572B (en) | A kind of Chinese medicine for treating chronic colitis | |
| CN113663016A (en) | Pharmaceutical composition and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |